Drug Profile
Research programme: G protein-coupled receptor modulators - Evotec SE/Takeda Cambridge
Latest Information Update: 26 Sep 2019
Price :
$50
*
At a glance
- Originator Evotec AG; Takeda Cambridge
- Developer Evotec SE; Takeda Cambridge
- Class Small molecules
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported CNS disorders; Metabolic disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in CNS-disorders in Germany
- 16 Jul 2016 No recent reports of development identified for research development in Metabolic-disorders in Germany
- 21 Jan 2011 Early research in CNS disorders in Germany (unspecified route)